Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 651

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 651
---
 Audit Committee                               | ​ | ​ | ​                            | ​ | 10,000 | ​ | ​ | ​ | ​                                                                                 | ​ | 20,000 | ​ | ​ |
| Compensation Committee                        | ​ | ​ | ​                            | ​ |  7,500 | ​ | ​ | ​ | ​                                                                                 | ​ | 15,000 | ​ | ​ |
| Nominating and Corporate Governance Committee | ​ | ​ | ​                            | ​ |  5,000 | ​ | ​ | ​ | ​                                                                                 | ​ | 10,000 | ​ | ​ |

Cara also reimburses its non-employee directors for reasonable travel and out-of-pocket expenses incurred in connection with attending the Cara Board and committee meetings. Under the terms of the policy, Cara’s non-employee directors are also entitled to the following equity compensation: • Upon initial election to the Cara Board, a stock option having a Black-Scholes value of $350,000, with an exercise price equal to the fair market value of Cara’s common stock on the date of grant, with such option vesting over three years in 12 equal quarterly installments, subject to the director’s continued service as a director through each such vesting date. • On the date of each annual meeting of stockholders, (1) a stock option with a Black-Scholes value of $100,000 (or in the case of the Chairperson of the Board or Lead Independent Director, $200,000) with an exercise price equal to the fair market value of Cara’s common stock on the date of grant and (2) RSU grant with a grant date fair value of $100,000 (or in the case of the Chairperson of the Board or Lead Independent Director, $200,000), with each such equity award vesting on the earlier of the first-year anniversary of the date of grant and Cara’s next annual meeting of stockholders, subject to the director’s continued service as a director through such vesting date. Following the consummation of the Merger, all equity compensation is expected to be granted in the form of options in lieu of options and RSUs. This policy is intended to provide a total compensation package that enables Cara to attract and retain qualified and experienced individuals to serve as directors and to align its directors’ interests with those of its stockholders. Securities Authorized for issuance under Equity Compensation Plans The following table summarizes Cara’s equity compensation plan information as of December 31, 2024.

| Plan